Effects of an adverse-drug-event alert system on cost and quality outcomes in community hospitals

American Journal of Health-System Pharmacy

Volumn 67, Issue 8, 2010, Pages 613-620

  Piontek, Frank ^a   Kohli, Rajiv ^b   Conlon, Paul ^c   Ellis, Jeffrey J ^a   Jablonski, Jason ^d   Kini, Narendra ^e  

^a TRINITY HEALTH   (United States)

^b The College of William and Mary   (United States)

^c Clinical Quality and Patient Safety   (United States)

^d Saint Joseph Regional Medical Center South Bend   (United States)

^e MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

Adverse reactions; Computers; Costs; Drugs; Economics; Hospitals; Mortality; Outcomes; Pharmacy, institutional, hospital; Quality assurance

Indexed keywords

AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; CREATININE; DIGOXIN; ENOXAPARIN; HALOPERIDOL; KETOROLAC; MAGNESIUM; METFORMIN; PHENYTOIN; POTASSIUM;

ADVERSE DRUG REACTION; ALGORITHM; ARTICLE; COMMUNITY HOSPITAL; COMORBIDITY; COMPUTER ALERT SYSTEM; COMPUTER SYSTEM; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DATA BASE; DIAGNOSIS RELATED GROUP; DISEASE SEVERITY; DRUG COST; DRUG MONITORING; ELECTRONIC MEDICAL RECORD; HEALTH CARE QUALITY; HEALTH ECONOMICS; HOSPITAL CARE; HOSPITAL COST; HOSPITAL INFORMATION SYSTEM; HOSPITAL PATIENT; HOSPITAL PHARMACY; HUMAN; HYPERKALEMIA; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDICATION ERROR; MORTALITY; NEPHROTOXICITY; NEUTROPENIA; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEDATION; THROMBOCYTOPENIA; COST; DRUG SURVEILLANCE PROGRAM; ECONOMICS; EPIDEMIOLOGY; FACTUAL DATABASE; HOSPITAL READMISSION; HOSPITALIZATION; ORGANIZATION AND MANAGEMENT; TREATMENT OUTCOME; UNITED STATES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; BIAS (EPIDEMIOLOGY); COSTS AND COST ANALYSIS; DATABASES, FACTUAL; DIAGNOSIS-RELATED GROUPS; HOSPITAL MORTALITY; HOSPITALIZATION; HOSPITALS, COMMUNITY; HUMANS; PATIENT READMISSION; PHARMACY SERVICE, HOSPITAL; QUALITY ASSURANCE, HEALTH CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 77953623306     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp090056     Document Type: Article

References (42)

1. Bobb A, Gleason K, Husch M et al. The epidemiology of prescribing errors. Arch Intern Med. 2004; 164:785-92.
2. Leape LL, Brennan TA, Laird N et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. New Engl J Med. 1991; 324:377-84.
3. Bates DW, Cullen DJ, Laird N et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995; 274:29-34.
4. Classen DC, Pestotnik SL, Evans RS et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997; 277:301-6.
5. Bates DW, Spell N, Cullen DJ et al. The costs of adverse drug events in hospitalized patients. JAMA. 1997; 277:307-11. (Pubitemid 27045011)
6. Cullen DJ, Sweitzer BJ, Bates DW et al. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997; 25:1289-97.
7. Murff HJ, Patel VL, Hripcsak G et al. Detecting adverse events for patient safety research: a review of current methodologies. J Biomed Inform. 2003; 36:131-43. (Pubitemid 37209987)
8. Koch KE. Use of standardized screening procedures to identify adverse drug reactions. Am J Hosp Pharm. 1990; 47:1314-20.
9. Cullen DJ, Bates DW, Small SD et al. The incident reporting system does not detect adverse drug events; a problem for quality improvement. Jt Comm J Qual Improv. 1995; 10:541-8.
10. Bennett BS, Lipman AG. Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions. Am J Hosp Pharm. 1977; 34:931-6.
11. Classen DC, Pestotnik SL, Evans RS et al. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991; 266:2847-51. [Erratum, JAMA. 1992; 267:1922.]
12. Raschke RA, Gollihare B, Wunderlich TA et al. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. JAMA. 1998; 280:1317-20. [Erratum, JAMA. 1999; 281:420.]
13. Bates DW, Evans RS, Murff H et al. Detecting adverse events using information technology. J Am Med Inform Assoc. 2003; 10:115-28.
14. Senst BL, Achusim LE, Genest R et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health-Syst Pharm. 2001; 58:1126-32.
15. Wolfstadt JI, Gurwitz JH, Field TS et al. The effect of computerized order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med. 2008; 23:451-8.
16. Nebeker JR, Hoffman JM, Weir CR et al. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med. 2005; 165:1111-6.
17. Levit K, Ryan K, Elixhauser A et al. Health Care Utilization Project Facts and Figures: Statistics on hospital-based care in the United States in 2005. Agency for Healthcare Research and Quality. 2007. http://www.hcup-us.ahrq. gov/reports.jsp (accessed 2009 Feb 1).
18. Middleton B, Hammond WE, Brennan PF et al. Accelerating U.S. EHR adoption: how to get there from here. Recommendations based on the 2004 AMI retreat. J Am Med Inform Assoc. 2005; 12:13-9.
19. Jha AK, Kuperman GJ, Rittenberg E et al. Identifying hospital admissions due to adverse drug events using a computerbased monitor. Pharmacoepidemiol Drug Saf. 2001; 10:113-9. (Pubitemid 32590942)
20. Kelly WN. Potential risks and prevention, part 1: fatal adverse drug events. Am J Health-Syst Pharm. 2001; 58:1317-24.
21. Crandall DK, Brokel JM, Schwichtenberg T et al. Redesigning care delivery through health IT implementation. Exploring Trinity Health's IT model. J Healthc Inf Manag. 2007; 21:41-8.
22. Piontek FA, Coscia R, Marselle CS et al. Impact of American College of Surgeons verification on trauma outcomes. J Trauma. 2003; 54:1041-7.
23. Desikan R, Krauss MJ, Dunagan WC et al. Reporting of adverse drug events: examination of a hospital incident reporting system. In: Henriksen K, Battles J, Marks E et al., eds. Advances in patient safety: from research to implementation. Vol 1. Rockville, MD: Agency for Healthcare Research and Quality; 2005.
24. Leary RS, Johantgen ME, Farley D et al. All-payer severity-adjusted diagnosisrelated groups: a uniform method to severity-adjust discharge data. Top Health Inf Manage. 1997; 17:60-71.
25. Selker HP. Systems for comparing actual and predicted mortality rates: characteristics to promote cooperation in improving hospital care. Ann Intern Med. 1993; 118:753-61.
26. DesHarnais SI, Chesney J, Wroblewski R et al. The risk-adjusted mortality index: a new measure of hospital performance. Med Care. 1988; 26:1129-48.
27. Kohli R, Tan JK, Piontek FA et al. Integrating cost information with health management support systems: an enhanced methodology to assess health care quality drivers. Top Health Inform Manage. 1999; 20:80-95.
28. Byar DP. Why data bases should not replace randomized clinical trials. Biometrics. 1980; 36:337-42.
29. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997; 127:757-63.
30. Rubin DB. The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Statist Med. 2007; 26:20-36.
31. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998; 17:2265-81.
32. Hulshizer R, Blalock EM. Post hoc pattern matching: assigning significance to statistically defined expression patterns in single channel microarray data. BMC Bioinformatics. 2007; 8:240.
33. Kadono K, Homma T, Kamahara K et al. Effect of heavy-ion radiotherapy on pulmonary function in stage I non-small cell lung cancer patients. Chest. 2002; 122:1925-32.
34. Koppel R, Metlay JP, Cohen A et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA. 2005; 10:1197-203. (Pubitemid 40327905)
35. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA. 1997; 277:312-7.
36. Leape LL, Bates DW, Cullen DJ et al. Systems analysis of adverse drug events. JAMA. 1995; 274:35-43.
37. Prybys KM. Deadly drug interactions in emergency medicine. Emerg Med Clin North Am. 2004; 22:845-63.
38. Seger AC, Jha AK, Bates DW. Adverse drug event detection in a community hospital utilizing computerized medication and laboratory data. Drug Saf. 2007; 30:817-24.
39. Krahenbuhl-Melcher A, Schlienger R, Lampert M et al. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007; 30:379-407.
40. Kim HW. Business process versus coordination process in organizational change. Int J Flexible Manuf Syst. 2000; 12:275-90.
41. Des Jarlais DC, Lyles C, Crepaz N et al. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health. 2004; 94:361-6. (Pubitemid 38269486)
42. Norris SL, Atkins D. Challenges in using nonrandomized studies in systematic reviews of treatment interventions. Ann Intern Med. 2005; 142:1112-9.